IMPLICATIONS FOR PATIENT CARE: More accurate staging of recurrent PCa might lead to more beneficial decision making and patient management; a theranostic use of PSMA radioligands should be considered in recurrent PCa. Here, FOLH1 is linked to posterior cortical atrophy.